Sarepta Therapeutics Inc (SRPT)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 3,963,170 | 3,264,580 | 3,128,370 | 3,147,970 | 2,984,720 |
| Total stockholders’ equity | US$ in thousands | 1,527,740 | 859,337 | 384,950 | 928,009 | 761,759 |
| Financial leverage ratio | 2.59 | 3.80 | 8.13 | 3.39 | 3.92 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $3,963,170K ÷ $1,527,740K
= 2.59
The financial leverage ratio of Sarepta Therapeutics Inc has shown fluctuations over the past few years. As of December 31, 2020, the ratio was 3.92, indicating that the company's debt levels were 3.92 times its equity. By December 31, 2021, the ratio had decreased to 3.39, suggesting a slight improvement in the company's leverage position.
However, there was a significant spike in the financial leverage ratio by December 31, 2022, reaching 8.13, which could indicate a substantial increase in debt relative to equity during that period. This spike may raise concerns about the company's ability to manage its debt obligations effectively.
The ratio decreased to 3.80 by December 31, 2023, showing some improvement in the following year. By December 31, 2024, the financial leverage ratio further decreased to 2.59, indicating a lower reliance on debt financing compared to equity.
Overall, the trend in Sarepta Therapeutics Inc's financial leverage ratio demonstrates varying levels of leverage over the years, with fluctuations that may warrant further investigation into the company's debt management strategies and capital structure decisions.
Peer comparison
Dec 31, 2024